Day: May 6, 2023

HII Christens Virginia-Class Attack Submarine Massachusetts (SSN 798)

HII Christens Virginia-Class Attack Submarine Massachusetts (SSN 798)

Massachusetts (SSN 798) Christening From left, PCU Massachusetts (SSN 798) commanding officer Cmdr. Mike Siedsma, Newport News Shipbuilding President Jennifer Boykin, and Under Secretary of the Navy Erik Raven look on as Ship’s Sponsor Sheryl Sandberg performs the traditional honor of breaking a bottle of American sparkling wine across the bow of Virginia-class submarine Massachusetts (SSN 798) during the christening ceremony held Saturday, May 6, 2023 at HII’s Newport News Shipbuilding division. (Photo by Lexi Whitehead/HII) NEWPORT NEWS, Va., May 06, 2023 (GLOBE NEWSWIRE) — HII (NYSE: HII) today christened the Virginia-class submarine Massachusetts (SSN 798) at the company’s Newport News Shipbuilding division. “Shipbuilding is a noble calling, and you can see our pride in the craftsmanship before you,” NNS President Jennifer...

Continue reading

Deucrictibant Data Highlighted in Multiple Presentations at the C1-Inhibitor Deficiency and Angioedema Workshop

Deucrictibant Data Highlighted in Multiple Presentations at the C1-Inhibitor Deficiency and Angioedema Workshop

ZUG, Switzerland, May 06, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced two oral presentations and three poster presentations highlighting data from non-clinical and clinical studies of deucrictibant at the 13th C1-inhibitor Deficiency and Angioedema Workshop, being held from May 4-7, 2023, in Budapest, Hungary. “Today, two sequential presentations showed how PHVS416 (immediate-release deucrictibant capsules) provided symptom relief and resolution in the treatment of HAE attacks using the doses projected through the bradykinin challenge, our in vivo surrogate marker model,” said Peng Lu, M.D., Ph.D., Chief Medical Officer of Pharvaris. “The RAPIDe-1 study showed consistent...

Continue reading

Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry

Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry

Patients undergoing procedures enabled with OMNI® Surgical System technology experienced a greater average reduction in IOP-lowering medication usage compared to other MIGS procedures or cataract surgery alone MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve patients’ lives, today announced the results from a 12-month retrospective sub-analysis of IOP-lowering medication use following the three most commonly performed, FDA approved (or cleared) MIGS procedures in patients with mild stage glaucoma. Analysis included 16,789 patients in 4 different cohorts: 1) procedures enabled by OMNI® Surgical System technology in combination with cataract 2) iStent...

Continue reading

Credicorp Ltd.: Credicorp Ltd. Reports First Quarter 2023 Financial and Operating Results

Credicorp Ltd.: Credicorp Ltd. Reports First Quarter 2023 Financial and Operating Results

Lima, May 05, 2023 (GLOBE NEWSWIRE) — Credicorp Ltd. Reports First Quarter 2023 Financial and Operating Results ROE of 18.7% Driven by Resilient Core Income Cost of Risk Stable Sequentially Remaining High impacted by Social and Climatic Events in Peru Lima, Peru – May 5, 2023 – Credicorp Ltd. (“Credicorp” or “the Company”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia and Panama today reported its unaudited results for the quarter ended March 31, 2023. Financial results are expressed in Soles and are presented in accordance with International Financial Reporting Standards (IFRS). Effective 1Q23, the Company reports under IFRS 17 accounting standards for insurance contracts. While the impact on consolidated net income is not material, the reclassification...

Continue reading

Mueller Water Products to Participate in the Oppenheimer 18th Annual Industrial Growth Conference

Mueller Water Products to Participate in the Oppenheimer 18th Annual Industrial Growth Conference

ATLANTA, May 05, 2023 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) will virtually participate in the Oppenheimer 18th Annual Industrial Growth Conference on Tuesday, May 9, 2023, starting at 1:30 p.m. Eastern Time. About Mueller Water Products, Inc. Mueller Water Products, Inc. is a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America. Our broad product and service portfolio includes engineered valves, fire hydrants, pipe connection and repair products, metering products, leak detection, pipe condition assessment, pressure management products, and software technology that provides critical water system data. We help municipalities increase operational efficiencies, improve customer service and prioritize capital spending, demonstrating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.